Craig R. Stumpf

3.2k citations

23 papers · 2.0k indexed · 1 hit paper · h-index 13

Co-authors: Davide Ruggero Andrew C. Hsieh Yi Liu Pingda Ren Matthew R. Janes Michael Bonham Jonathan S. Weissman Nicholas T. Ingolia
Topics: RNA and protein synthesis mechanisms (9 papers)RNA modifications and cancer (7 papers)RNA Research and Splicing (7 papers)
Cited by: Aging Molecular Biology Cancer Research
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States India Germany

In The Last Decade

Craig R. Stumpf

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The translational landscape of mTOR signalling steers cancer initiation and metastasis

2012 978 citations Andrew C. Hsieh, Yi Liu et al. Nature profile →

Peers

Countries citing papers authored by Craig R. Stumpf

Since Specialization

Citations

This map shows the geographic impact of Craig R. Stumpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig R. Stumpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig R. Stumpf more than expected).

Fields of papers citing papers by Craig R. Stumpf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig R. Stumpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig R. Stumpf. The network helps show where Craig R. Stumpf may publish in the future.

Co-authorship network of co-authors of Craig R. Stumpf

This figure shows the co-authorship network connecting the top 25 collaborators of Craig R. Stumpf. A scholar is included among the top collaborators of Craig R. Stumpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig R. Stumpf. Craig R. Stumpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11 2024 ·Molecular Cancer Therapeutics ·Gregory S. Parker,Julia I. Toth,Sarah Fish,(unknown),(unknown),(unknown),(unknown),Craig R. Stumpf,Kenneth Steadman,(unknown),(unknown),(unknown),(unknown),Geoffray Leriche,(unknown),Peggy A. Thompson	3
2	Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven Tumors 2021 ·Frontiers in Oncology ·Adina Gerson‐Gurwitz,Nathan P. Young,Vikas Goel,Boreth Eam,Craig R. Stumpf,Joan Chen,Sarah Fish,(unknown),Eric Sung,Jocelyn Staunton,Gary G. Chiang,Kevin R. Webster,Peggy A. Thompson	22
3	A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in Mice 2020 ·Neurotherapeutics ·(unknown),June Bryan de la Peña,(unknown),Jonathan E. Ploski,Craig R. Stumpf,Kevin R. Webster,Catherine A. Thorn,Zachary T. Campbell	13
4	Abstract B133: eFT226, a first in class inhibitor of eIF4A1, targets FGFR1/2 and HER2 driven cancers 2019 ·Molecular Cancer Therapeutics ·Peggy A. Thompson,Nathan P. Young,Craig R. Stumpf,Boreth Eam,Vikas Goel,Joan Chen,Sarah Fish,Gregory S. Parker,Adina Gerson‐Gurwitz,(unknown),Eric Sung,Jocelyn Staunton,Gary G. Chiang,Christopher J. Wegerski,Samuel Sperry,Kevin R. Webster,Siegfried Reich	3
5	Abstract LB-068: Tomivosertib (eFT508), a potent and highly selective inhibitor of MNK1 and MNK2, enhances CAR T cell activity through modulating T cell differentiation 2019 ·Cancer Research ·Vikas Goel,Rajesh Sharma,Jocelyn Staunton,Craig R. Stumpf,Nathan P. Young,Peggy A. Thompson,Gary G. Chiang,Kevin R. Webster	0
6	Abstract 4343: A focused CRISPR screen to identify synthetic lethal interactions with the novel eIF4A inhibitor eFT226 in KRAS driven NSCLC 2019 ·Cancer Research ·Nathan P. Young,Craig R. Stumpf,Joan Chen,Gary G. Chiang,Peggy A. Thompson,Kevin R. Webster	2
7	Abstract 3855: Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response 2018 ·Cancer Research ·Craig R. Stumpf,Joan Chen,Vikas Goel,Gregory S. Parker,Gary G. Chiang,Peggy A. Thompson,Kevin R. Webster	4
8	Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade 2017 ·Cancer Research ·Kevin R. Webster,Vikas Goel,Jocelyn Staunton,(unknown),Gregory S. Parker,Craig R. Stumpf,(unknown),Gary G. Chiang,Christopher J. Wegerski,Samuel Sperry,Joan Chen,Vera Huang,Peggy A. Thompson,Chinh Tran,Justin T. Ernst,Stephen E. Webber,Paul A. Sprengeler,Siegfried Reich	3
9	The Translational Landscape of the Mammalian Cell Cycle 2013 ·Molecular Cell ·Craig R. Stumpf,(unknown),Adam B. Olshen,Barry S. Taylor,Davide Ruggero	165
10	Abstract A57: Plasticity of the translational landscape during the mammalian cell cycle: Implications and new insights for cancer cell proliferation 2013 ·Cancer Research ·Craig R. Stumpf,(unknown),Adam B. Olshen,Barry S. Taylor,Davide Ruggero	1
11	Investigating Myc-Dependent Translational Regulation in Normal and Cancer Cells 2013 ·Methods in molecular biology ·John T. Cunningham,Michael Pourdehnad,Craig R. Stumpf,Davide Ruggero	5
12	Context-dependent function of a conserved translational regulatory module 2012 ·Development ·(unknown),Craig R. Stumpf,Cristel G. Thomas,Marvin Wickens,Eric S. Haag	21
13	The translational landscape of mTOR signalling steers cancer initiation and metastasisbreakdown → 2012 ·Nature ·Andrew C. Hsieh,Yi Liu,(unknown),Nicholas T. Ingolia,Matthew R. Janes,(unknown),(unknown),Craig R. Stumpf,(unknown),Michael Bonham,Shunyou Wang,Pingda Ren,Michael Martin,Katti Jessen,Morris E. Feldman,Jonathan S. Weissman,Kevan M. Shokat,Christian Rommel,Davide Ruggero	978
14	The cancerous translation apparatus 2011 ·Current Opinion in Genetics & Development ·Craig R. Stumpf,Davide Ruggero	88
15	Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning 2011 ·Cell ·(unknown),Aya D. Pusic,Craig R. Stumpf,Kunihiko Shimizu,Andrew C. Hsieh,Shifeng Xue,Junko Ishijima,Toshihiko Shiroishi,Maria Barna	423
16	A single C. elegans PUF protein binds RNA in multiple modes 2009 ·RNA ·(unknown),Laura Opperman,Craig R. Stumpf,(unknown),Sündüz Keleş,Marvin Wickens	37
17	A 5′ cytosine binding pocket in Puf3p specifies regulation of mitochondrial mRNAs 2009 ·Proceedings of the National Academy of Sciences ·Deyu Zhu,Craig R. Stumpf,Joseph M. Krahn,Marvin Wickens,Traci M. Tanaka Hall	70
18	Analysis of RNA–Protein Interactions Using a Yeast Three-Hybrid System 2008 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Craig R. Stumpf,Laura Opperman,Marvin Wickens	22
19	A Caenorhabditis elegans PUF protein family with distinct RNA binding specificity 2008 ·RNA ·Craig R. Stumpf,Judith Kimble,Marvin Wickens	46
20	Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract 1997 ·Anti-Cancer Drugs ·Craig R. Stumpf,(unknown)	23

About Craig R. Stumpf

Craig R. Stumpf is a scholar working on Aging, Molecular Biology and Oncology, having authored 23 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (9 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Aging (62 citations), Molecular Biology (1.7k citations) and Cancer Research (196 citations). Craig R. Stumpf has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Davide Ruggero, Andrew C. Hsieh, Yi Liu, Pingda Ren, Matthew R. Janes, Michael Bonham, Jonathan S. Weissman, Nicholas T. Ingolia, Morris E. Feldman and Shunyou Wang. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact